Automatic Masseter Thickness Measurement and Ideal Point Localization for Botulinum Toxin Injection

Botulinum toxin injection is a highly efficacious treatment for masseter muscle hypertrophy, while manual injection point localization based on experience can be non-quantitative, subjective and therefore suboptimal and even side-effect risky. To address this important while challenging task, in this paper we present a methodology of automatic ideal point localization for botulinum toxin injection based on automatic segmentation, measurement and quantitative analysis. Specifically, we first present a novel three-dimensional (3D) fully convolutional neural network for fully automatic mandible and masseter regions of interest (RoI) localization and segmentation from head computed tomography (CT) images. Given the segmentation results, the ideal injection points on the face are located using ray casting based automatic thickness measurement. We conducted experiments on an internal dataset consisting of head CT images acquired from 53 patients to evaluate the segmentation performance and localization reliability. The results demonstrate that the segmentation framework outperforms the state-of-the-art method by a significant margin, and the localization system provides intuitive, interactive user interface and reliable injection point decisions.

[1]  N. Apaydın,et al.  The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter. , 2014, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[2]  Jian Sun,et al.  Deep Residual Learning for Image Recognition , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[3]  Hao Chen,et al.  3-D RoI-Aware U-Net for Accurate and Efficient Colorectal Tumor Segmentation , 2018, IEEE Transactions on Cybernetics.

[4]  Seyed-Ahmad Ahmadi,et al.  V-Net: Fully Convolutional Neural Networks for Volumetric Medical Image Segmentation , 2016, 2016 Fourth International Conference on 3D Vision (3DV).

[5]  J. V. von Lindern,et al.  Type A Botulinum Toxin for the Treatment of Hypertrophy of the Masseter and Temporal Muscles: An Alternative Treatment , 2001, Plastic and reconstructive surgery.

[6]  Corinne Horn,et al.  Botulinum toxin for masseter reduction in Asian patients. , 2004, Archives of facial plastic surgery.

[7]  Herve Raspaldo,et al.  Lower‐face and neck antiaging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus – part 2 , 2011, Journal of cosmetic dermatology.

[8]  Thomas Brox,et al.  3D U-Net: Learning Dense Volumetric Segmentation from Sparse Annotation , 2016, MICCAI.

[9]  Steven Liew,et al.  Nonsurgical reshaping of the lower face. , 2008, Aesthetic surgery journal.

[10]  Kyung-Seok Hu,et al.  Topography of the masseter muscle in relation to treatment with botulinum toxin type A. , 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[11]  R. Tabrizi,et al.  Correction of Lower Facial Wideness Due to Masseter Hypertrophy , 2010, The Journal of craniofacial surgery.

[12]  Hao Chen,et al.  3D deeply supervised network for automated segmentation of volumetric medical images , 2017, Medical Image Anal..

[13]  Hao Chen,et al.  Volumetric ConvNets with Mixed Residual Connections for Automated Prostate Segmentation from 3D MR Images , 2017, AAAI.

[14]  Herve Raspaldo,et al.  Upper‐ and mid‐face anti‐aging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus – part 1 , 2011, Journal of cosmetic dermatology.